Multi-site investigation of strategies for the clinical implementation of preemptive pharmacogenetic testing

PURPOSE: The increased availability of clinical pharmacogenetic (PGx) guidelines and decreasing costs for genetic testing have slowly led to increased utilization of PGx testing in clinical practice. Preemptive PGx testing, where testing is performed in advance of drug prescribing, is one means to e...

Descripción completa

Detalles Bibliográficos
Autores principales: Duarte, Julio D., Dalton, Rachel, Elchynski, Amanda L., Smith, D. Max, Cicali, Emily J., Lee, James C., Duong, Benjamin Q., Petry, Natasha J., Aquilante, Christina L., Beitelshees, Amber L., Empey, Philip E., Johnson, Julie A., Obeng, Aniwaa Owusu, Pasternak, Amy L., Pratt, Victoria M., Ramsey, Laura B., Tuteja, Sony, Van Driest, Sara L., Wiisanen, Kristin, Hicks, J. Kevin, Cavallari, Larisa H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8633054/
https://www.ncbi.nlm.nih.gov/pubmed/34282303
http://dx.doi.org/10.1038/s41436-021-01269-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8633054/
https://www.ncbi.nlm.nih.gov/pubmed/34282303
http://dx.doi.org/10.1038/s41436-021-01269-9

Ejemplares similares